Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.68
-0.06 (-3.45%)
At close: Jun 17, 2025, 3:07 PM

Gain Therapeutics Revenue

Gain Therapeutics reported an annual revenue of $0, reflecting a -100% growth. For the quarter ending March 31, 2025, Gain Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
-100%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
23
Market Cap
50.31M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.